NanoPass Technologies Ltd: Clinical Trials

8 trials sponsored by NanoPass Technologies Ltd, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 1 active not recruiting. 3 Not applicable, 2 Phase 1, 2 Phase 2, 1 Early Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable3Completed 3
Phase 12Active not recruiting 1, Completed 1
Phase 22Active not recruiting 1, Completed 1
Early Phase 11Completed 1
Phase 31Completed 1

Follow NanoPass Technologies Ltd: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Vaccine Therapy Plus Pembrolizumab in Treating Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer
Biopsy, Biospecimen Collection, Computed Tomography - Fallopian Tube Carcinosarcoma, Primary Peritoneal Carcinosarcoma
Phase 1 / Phase 2Active not recruitingMayo Clinic382023-09-282026-09-21
Proof-of-concept Study of LymphMonitor 1.0 to Assess the Lymphatic Vessel Function
Lymphatic clearance measurement - Lymphedema, Secondary Lymphedema
Phase 1CompletedNicole Lindenblatt102020-05-222020-07-14
Intradermal Lidocaine Via MicronJet600 Microneedle Device
Intravenous cannulation after intradermal injection of lidocaine via MicronJet600 microneedle device (1), Intravenous cannulation after intradermal injection of saline via MicronJet600 microneedle device, Intravenous cannulation after intradermal injection of lidocaine via MicronJet600 microneedle device (2) - Local Anaesthesia
Not applicableCompletedI.M. Sechenov First Moscow State Medical University1022019-01-292021-11-05
Immunogenicity of Inactivated and Live Polio Vaccines
Group A: Trivalent Oral Polio Vaccine, Group B: Bivalent Oral Polio Vaccine, Group C: Inactivated Polio Vaccine - Poliomyelitis
Phase 3CompletedCenters for Disease Control and Prevention12062012-11-012014-01-09
Intradermal Versus Intramuscular Polio Vaccine Booster in HIV-Infected Subjects
IPOL (Sanofi Pasteur) inactivated polio vaccine booster dose - Polio Immunity
Phase 2CompletedEastern Virginia Medical School2312012-09-012015-02-05
A Pilot Study to Assess the Safety, PK and PD of Insulin Injected Via MicronJet or Conventional Needle
MicronJet - Intradermal Injections
Early Phase 1CompletedNanoPass Technologies Ltd232008-03-012013-05-10
A Study to Assess the Safety and Efficacy of a Microneedle Device for Local Anesthesia
MicronJet - Local Anesthesia, Intradermal Injections
Not applicableCompletedNanoPass Technologies Ltd402007-10-012013-05-10
A Pilot Study to Evaluate the Safety and Immunogenicity of Low Dose Flu Vaccines
Flu Vaccine (FLUARIX®) - Influenza, Human
Not applicableCompletedNanoPass Technologies Ltd1802007-05-012013-05-10

Conditions studied

Fallopian Tube Neoplasms (1)  ·  Influenza, Human (1)  ·  Lymphedema (1)  ·  Ovarian Neoplasms (1)  ·  Poliomyelitis (1)

Interventions

Biopsy (1)  ·  Blood Component Removal (1)  ·  Influenza Vaccines (1)  ·  Magnetic Resonance Spectroscopy (1)  ·  Poliovirus Vaccine, Inactivated (1)  ·  Specimen Handling (1)  ·  fluarix (1)  ·  pembrolizumab (1)

Countries

United States (2)  ·  Bangladesh (1)  ·  Russia (1)  ·  Switzerland (1)

Top investigators

Abhijeet Anand, MBBS, MPH (1)  ·  Chavdar Dr Pavlov, MD, PhD (1)  ·  Itamar Raz, MD (1)  ·  Jacob Atsmon, MD (1)  ·  K. Zaman, MBBS, PhD (1)  ·  Matthew S. Block, MD, PhD (1)  ·  Nicole Lindenblatt, M.D, PhD (1)  ·  Pierre Van Damme, MD, PhD (1)  ·  Stephanie B Troy, MD (1)

Results publications

PMID 25567841, PMID 35100279

NIH funding

2019 (1), R01CA276313 (1)